Category Archives: Genomics

Knowing thy genome: The science and ethics of personal genome sequencing

Posted on July 10, 2012 by Hema Bashyam

Until not too long ago, asking “Who am I?” of oneself often meant undertaking a voyage of self-discovery either through travel to a faraway land or through time-limited visits to a therapist’s couch. We now live in an era that … Continue reading →

Posted in Bioinformatics, Education programs, Genomics | Tagged , | Leave a comment

2012 “Biology of Genomes” in 140 ch@r@cters

Posted on May 25, 2012 by Hema Bashyam

CSHL’s annual “The Biology of Genomes” meeting, held May 8-12 this year, has come to be known as the yearly shindig for researchers working in the vast and rapidly growing field of genomics. Named one of the top scientific conferences … Continue reading →

Posted in Bioinformatics, Education programs, Genomics, Meetings | Tagged , | Leave a comment

CSHL’s sequencing power gets a fresh boost

Posted on August 12, 2011 by Hema Bashyam

At CSHL’s Woodbury Genome Center a decade ago, it took 12 technicians working in two shifts and six “first generation” sequencing machines to sequence 70 million bases of DNA—repeats of A, T, G, C—in a single month. By 2007, as … Continue reading →

Posted in Bioinformatics, Cancer, Disease research, Genomics, Neuroscience, Plant Biology | Tagged , , , , | 1 Comment

Collaboration column: A new gene-hunting strategy locates genetic cause of a rare disease

Posted on April 14, 2011 by Hema Bashyam

With an ingenious combination of next-generation sequencing, conventional gene mapping and bioinformatics detective work, an Israeli-led collaboration that includes CSHL scientists has helped a Palestinian family to confront the genetic culprit behind a rare, hereditary neurological disease that afflicts some … Continue reading →

Posted in Bioinformatics, Disease research, Genomics | Tagged , , | Leave a comment

Collaboration column: SMA therapeutics and potential drug target for schizophrenia

Posted on March 11, 2011 by Hema Bashyam

CSHL researchers are part of two highly successful, multi-institutional collaborations that report exciting advances in developing therapeutics for a devastating neuromuscular disorder and in finding a ‘druggable’ target for schizophrenia. For several years now, CSHL’s Adrian Krainer has devoted his expertise in … Continue reading →

Posted in Disease research, Genomics, Neuroscience | Tagged , , , , , | 1 Comment